Sanofi-Aventis CR`s Cash Conversion Cycle reached 89.5 days in 2017. This is 0.08699999999999999 % less than in the previous year.
Buy Cash Conversion Cycle data for Sanofi-Aventis Czech Republic.
$19.99Buy all data for Sanofi-Aventis Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | days | ... | ... | ... | ... | ... | 75.5 | 97.4 | 37.7 | 68.6 | 37.6 | ||||||||
| Bayer Czech Republic | days | ... | ... | ... | 21.7 | 36.1 | 37.5 | 32.0 | 40.3 | ||||||||||
| GlaxoSmithKline Czech Republic | days | ... | ... | ... | 111 | 117 | 126 | 94.5 | 85.4 | ||||||||||
| Merck Czech Republic | days | ... | ... | 94.1 | 99.5 | 110 | 93.1 | 93.1 | |||||||||||
| Novartis Czech Republic | days | 55.8 | 45.2 | 123 | 71.0 | 66.1 | |||||||||||||
| Pfizer Czech Republic | days | ... | ... | 83.6 | 60.5 | 69.8 | 36.9 | 131 | |||||||||||
| Roche Czech Republic | days | ... | ... | ... | 47.6 | 74.5 | 101 | 136 | 127 | ... | |||||||||
| Sanofi-Aventis Czech Republic | days | ... | ... | ... | ... | 95.7 | 97.0 | 90.4 | 70.6 | 79.3 | |||||||||
| Servier Czech Republic | days | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 37.2 | 19.6 | 33.3 | 40.5 | ||
| Walmark | days | ... | ... | ... | 114 | 64.0 | 31.2 | 5.58 | 66.0 |
Helgi Library 
